Systems and methods for discriminating effects on targets
AssigneeRecursion Pharmaceuticals, Inc.
InventorsMason L. Victors, Blake C. Borgeson, Cedric St-Jean-Leblanc
Life of this patent
Estimating the term…
Loading patent…
AssigneeRecursion Pharmaceuticals, Inc.
InventorsMason L. Victors, Blake C. Borgeson, Cedric St-Jean-Leblanc
Estimating the term…
Systems and methods for determining whether a set of test perturbations discriminates over a null distribution for an on target effect against a first component of an entity are disclosed. The perturbations are perturbations of the first component and the entity comprises a plurality of components. For each perturbation in the set, a corresponding vector comprising a plurality of elements, is obtained. Each element comprises a distribution metric of measurements of a feature across instances of the entity upon exposure to the respective perturbation or (ii) a distribution metric of a respective dimension reduction component computed using the measurement of the plurality of features across instances of the entity upon the perturbation exposure. A composite metric is computed, using the vectors, and compared to a null distribution. When the composite metric is differentiated from the null distribution, the set of perturbations is deemed to discriminate the on target effect against the first component over the null distribution.
A method for determining whether a set of test perturbations discriminates over a null distribution for an on target effect against one or more first genetic components of a cell, wherein the set of test perturbations comprises a plurality of test perturbations against the one or more first genetic components and the cell comprises a plurality of genetic components including the first one or more genetic components, the method comprising:
Dependencies are inferred from the claim text.